Glucagon-Like-Peptide-1 receptor agonists (GLP-1 RA) are a class of medications originally developed to treat type 2 diabetes, but have since gained widespread attention for their effects on weight loss and metabolic health. Emerging research suggests that GLP1-Receptor Agonists could be supportive in managing inflammatory symptoms associated with Mast Cell Activation Syndrome (MCAS). Although research is currently limited, Anna talks about what we know so far and her experience with clients taking these drugs in clinical practice. 

Website: http://annamarsh.co.uk/

Instagram: https://www.instagram.com/anna_marsh_nutrition/

Research Paper: https://www.sciencedirect.com/science/article/abs/pii/S0002962925011061

Take the Fatigue Recovery Quiz: https://app.annamarsh.co.uk/quiz

New Nurturing Resilience Membership: https://annamarsh.co.uk/nurturing-resilience/